UVADEX ( DrugBank: - )

3 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	2
51	全身性強皮症	1
96	クローン病	4

46. 悪性関節リウマチ

臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2004-001825-69-IT (EUCTR)	04/11/2005	14/12/2005	A Multi Center, Open label, Extension study of RA 1 using Extracoproreal photoimmune therapy with Uv ...	A Multi Center, Open label, Extension study of RA 1 using Extracoproreal photoimmune therapy with Uv ...	Rheumatoid arthritis MedDRA version: 6.1;Level: PT;Classification code 10039073	Trade Name: UVADEX INN or Proposed INN: Methoxsalen	THERAKOS	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	68		Italy
2	NCT00221000 (ClinicalTrials.gov)	August 2003	13/9/2005	Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEXfor the Treatment of Rheumatoid ...	A Phase II, Multicenter, Randomized, Double-blind, Sham Pheresis-controlled, Study of Extracorporeal ...	Rheumatoid Arthritis	Drug: Methoxsalen;Procedure: Extracorporeal Photopheresis	Mallinckrodt	NULL	Completed	18 Years	N/A	Both	86	Phase 2	United States;Australia;Austria;Belgium;Canada;France;Germany;Italy;Mexico;Slovakia;South Africa

First Previous1Next Last

51. 全身性強皮症

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04986605 (ClinicalTrials.gov)	December 1, 2023	1/6/2021	Extracorporeal Photopheresis in Early Diffuse Cutaneous Systemic Sclerosis	The Effectiveness of ECP in Diffuse Cutaneous Systemic Sclerosis	Diffuse Cutaneous Systemic Sclerosis	Device: Extracorporeal Photopheresis (ECP);Drug: UVADEX	Lawson Health Research Institute	Mallinckrodt	Not yet recruiting	18 Years	N/A	All	15	Phase 2	Canada

First Previous1Next Last

96. クローン病

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2004-002693-37-DE (EUCTR)	14/03/2005	06/01/2005	A MULTICENTER, OPEN-LABEL, STUDY OF EXTRACORPOREAL PHOTOIMMUNE THERAPY WITH UVADEXIN THE TREATMENT O ...	A MULTICENTER, OPEN-LABEL, STUDY OF EXTRACORPOREAL PHOTOIMMUNE THERAPY WITH UVADEXIN THE TREATMENT O ...	Patients with Moderately Active Crohn’s Disease Who Are Refractory or Intolerant to Immunosuppressan ...	Trade Name: UVADEX INN or Proposed INN: methoxsalen	Therakos	NULL	Not Recruiting			Female: yes Male: yes	25		Germany
2	EUCTR2004-002693-37-AT (EUCTR)	10/12/2004	05/11/2004	A MULTICENTER, OPEN-LABEL, STUDY OF EXTRACORPOREAL PHOTOIMMUNE THERAPY WITH UVADEXIN THE TREATMENT O ...	A MULTICENTER, OPEN-LABEL, STUDY OF EXTRACORPOREAL PHOTOIMMUNE THERAPY WITH UVADEXIN THE TREATMENT O ...	Patients with Moderately Active Crohn’s Disease Who Are Refractory or Intolerant to Immunosuppressan ...	Trade Name: UVADEX INN or Proposed INN: methoxsalen	Therakos	NULL	Not Recruiting			Female: yes Male: yes	25		Austria;Germany
3	NCT00221026 (ClinicalTrials.gov)	December 2004	13/9/2005	Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEXfor the Treatment of Crohn's Di ...	A Multicenter, Open-Label, Study of Extracorporeal Photoimmune Therapy With UVADEXin the Treatment o ...	Crohn's Disease	Drug: Methoxsalen +ECP;Procedure: Extracorporeal Photopheresis	Mallinckrodt	ICON plc	Completed	18 Years	N/A	Both	25	Phase 2	United States;Austria;Belgium;Germany
4	NCT00056355 (ClinicalTrials.gov)	March 2003	10/3/2003	Extracorporeal Photopheresis to Maintain Symptoms Remission During Steroid Withdrawal in Patients Wi ...	A Single Arm Study of Extracorporeal Photoimmune Therapy With UvadexFor Corticosteroid Sparing in Pa ...	Crohn Disease	Drug: UVADEX and UVAR XTS Photopheresis System	National Institute of Allergy and Infectious Diseases (NIAID)	NULL	Completed	N/A	N/A	Both	10	Phase 1	United States

First Previous1Next Last

先頭へ